Table 1.
The frequency distribution of side effects and improvement of symptoms in the vulvovaginal candidiasis, bacterial vaginosis, and nonspecific vaginitis groups.
| Groups | Side effects | Chlorhexidine vaginal gel | Clotrimazole vaginal gel | Oral metronidazole | Combination therapy (oral metronidazole and clotrimazole vaginal gel) |
|---|---|---|---|---|---|
| Vulvovaginal candidiasis (N=34) | Vaginal burning | 14 (82.35%) | 14 (82.35%) | - | - |
| Nausea | 0 | 0 | - | - | |
| Vomiting | 0 | 0 | - | - | |
| Cutaneous lesions | 0 | 1 (5.88%) | - | - | |
| Improvement | 15 (88.23%) | 16 (94.11%) | - | - | |
| Bacterial vaginosis (N=41) | Vaginal burning | 10 (43.47%) | - | 2 (11.11%) | - |
| Nausea | 0 | - | 1 (5.55%) | - | |
| Vomiting | 0 | - | 1 (5.55%) | - | |
| Cutaneous lesions | 0 | - | 0 | - | |
| Improvement | 23 (100%) | - | 18 (100%) | - | |
| Nonspecific vaginitis (N=36) | Vaginal burning | 5 (27.77%) | - | - | 6 (33.33%) |
| Nausea | 0 | - | - | 0 | |
| Vomiting | 0 | - | - | 0 | |
| Cutaneous lesions | 3 (16.66%) | - | - | 0 | |
| Improvement | 18 (100%) | - | - | 18 (100%) |